Topic: induced pluripotent stem cells
A Tufts University-led team has developed 3D models of the central nervous system that might prove useful for drug discovery.
Researchers from Cincinnati Children’s have grown esophageal organoids entirely from stem cells. Their work could yield treatments for GI diseases.
A newly found stem cell can differentiate into just bone cells without the unwanted lineages found in previous cultures.
Implanted iPSC-derived, scaffold-based liver tissues produced promising results in mice with tyrosinemia.
Scientists in the U.S. and Japan devised a new tissue engineering method to tackle blood supply problems in pancreatic cell transplantation.
A Salk Institute team found that transplanting liver cells into hemophilic mice restored their ability to form blood clots.
Scientists at Stanford University believe stem cells can teach the immune system to recognize and attack cancer.
Astellas has bought out a U.S. biotech that wants to ensure cell therapy products aren’t rejected by a patient’s immune system.
A team at Duke University has created the first functioning human muscle from skin cell-derived induced pluripotent stem cells.
Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.